News

Set up a blog in just a few minutes

Business impacts of not registering for REACH on time

The last deadline is looming and there are serious consequences to not meeting it by 31 May At the start of the year, Echa was still expecting about 25,000 unique substances covered by some 60,000 registrations, to be submitted by the last REACH deadline of 31...

In 2015, ECHA focused its dossier evaluation activities on substances that matter the most for human health and the environment. In the majority of the cases, data on one or more key endpoints was missing to conclude whether the substance is of concern or not. ECHA encourages registrants to read and follow the recommendations of its report to improve their dossiers

In 2015, ECHA followed its new compliance check strategy to prioritise and select substances that raise potential concern. The focus was on checking high-tonnage registration dossiers with human health and environmental data gaps and with a high potential for worker, consumer or environmental exposure. Dossiers of...

Companies need to apply for approval of a biocidal active substance used for treating articles if the substance is not yet part of the approval process.

According to the Biocidal Products Regulation, articles treated with biocidal products can only be placed on the market if the active substances are approved in the EU. The deadline to apply for the approval of active substances which are used in treated articles and not yet...

First pilot project on authorisation finds only three cases of non-compliance. The aim of the project was to check compliance with the REACH Regulation on the marketing and use of MDA and Musk xylene. Out of 421 inspections, only three non-compliances were found.

The Forum for Exchange of Information on Enforcement conducted the pilot project, that was limited to a compliance check of two substances: Musk xylene and 4,4'-Diamoniodiphenylmethane (MDA). The substances have the earliest sunset date (21 August 2014) in Annex XIV under REACH. 18 Member States participated...

An external report suggests that further improvements can be made to substance evaluation under REACH. While significant advances have been made, the report recommends changes to improve workability and efficient use of resources for registrants and authorities.

A report commissioned by ECHA to assess the effectiveness, efficiency, transparency and workability of substance evaluation under REACH, found the information on ECHA's website to be fairly comprehensive and fit for purpose. The report mentions several positive aspects, particularly noting the valuable contribution that the integrated...

The Biocidal Products Committee (BPC) has adopted opinions supporting the approval of three active substances for use in biocidal products used as disinfectants and insecticides.

The active substances are: Bacillus thuringiensis subsp. Kurstaki, Serotype 3a3b, Strain ABTS-351 for product-type 18 Citric acid for product-type 2 Cyfluthrin for product-type 18 The conclusion of the committee is that these substances in the relevant product-types may be approved. The adopted opinions will serve as a basis for...

ECHA has launched a public consultation on 27 applications for authorisation covering 39 uses of:

Chromium VI compounds used in surface treatment, hard and functional chrome plating, cooling systems, passivation of tin plates, production of copper foils, production of coloured stainless steel, and manufacture of sodium chlorate/chlorite. These uses take place in various industry sectors such as chemical industry, aerospace,...

The Agency has selected nearly 300 substances from REACH registrations for further scrutiny by the Member State competent authorities. The competent authorities will carry out a manual examination of the dossiers they prioritise to decide whether there is a need for regulatory action.

The shortlisted substances are registered by nearly 1 500 companies in 2 500 registration dossiers. The selection is based on an automated IT screening focusing on substances with potential carcinogenic, mutagenic or toxic to reproduction (CMR), persistent, bioaccumulative and toxic (PBT), endocrine-disrupting, sensitising or specific...

Last year, the Member State competent authorities redefined all in situ generated active substances in the Review Programme. Notifications for alternative precursors or systems for in situ generation have to be submitted by 27 April 2016.

The notifications may also need to be submitted for the active substance as originally defined before the redefinition (i.e. not in situ generated). An example where notifying such a manufactured active substance may be appropriate is sulphur dioxide. It is now re-defined as "sulphur dioxide...

The new Implementing Regulation adopted by the European Commission requires ECHA to make sure that all companies registering the same substance are part of the same registration. To implement this requirement, the dossier submission tool REACH-IT is being adapted to reject submissions outside of a joint registration and is, therefore, closed. The tool will re-open on 27 January at 10:00 EET.

As of 27 January, you will no longer be able to submit a registration dossier separately if a registration for the same substance already exists. Similarly, you will not be able to update your registration, which has been submitted individually, if another registration for the same...

In 2015, ECHA started applying its new compliance check strategy: it focused on checking the dossiers of substances that matter the most for the protection of people and the environment

This meant high-tonnage registration dossiers with important data gaps and with a high potential for worker, consumer or environmental exposure. ECHA checked the dossiers of 107 high priority substances for compliance. In most cases, the Agency drafted a decision requesting the registrant for the missing...